Infection Prevention Market

Infection Prevention Market Outlook (2024 to 2034)

The global infection prevention industry is on a collision course with global dominance in the future decade. Global infection prevention revenue is expected to reach around USD 40,845.2 million by 2024. The market is expected to increase at a 3.1% CAGR between 2024 and 2034, reaching a value of USD 55,379.1 million by that year.

Attributes	Key Statistics
Expected Base Year Value (2024)	USD 40,845.2 million
Anticipated Forecast Value (2034)	USD 55,379.1 million
Estimated Growth (2024 to 2034)	3.1% CAGR

Key Market Highlights

Advanced Utilization of E-Beam Sterilization

• Market growth is influenced by the kind of chemicals employed as agents and the availability of various goods depending on heat sensitivity. One may be interested in the medical equipment or substance utilized in autoclaving and sterilizing processes, such as liquid or radiation sterilization.
• Medical equipment and pharmaceutical packaging materials are frequently sterilized using e-beam or beta irradiation. Extremely dense materials, often used for low- to medium-density items, are inappropriate for this treatment. It has the advantages of simple, clean on/off technology and rapid switch terminal sterilization.
• Products can be sterilized using an e-beam for a short period, eliminating the chance of radiation compatibility issues. E-beam sterilizing takes around five to seven minutes on average and helps to reduce handling and related dangers. For the argument's sake, the infection control market is projected to develop significantly throughout the forecast period.

Increasing Rate for Surgeries Drives Demand for Infection Prevention

• The market is mainly driven by an increase in surgical and clinical procedures that need intense infection prevention.
• The number of surgical operations performed globally has increased. This is due to a rise in the frequency of lifestyle illnesses, increased obesity, and other factors.
• In addition, several athletes experience severe injuries, particularly those to the spine and elbows. As a result, many operations have increased the need for infection prevention kits.
• Positive clinical results related to infection control account for the high preference.
• Since hospitals, clinics, pharmacies, and manufacturers of medical devices now require more sterilization and disinfection, the COVID-19 epidemic has benefited market growth.

Historical Analysis of the Infection Prevention Market

The worldwide infection prevention market is likely to witness a significant shift over the next ten years. Between 2024 and 2034, analysts predict a 3.1% CAGR, which is below the steady but modest 3.6% rate expected for 2019 through 2023.

Attributes	Key Statistics
Expected Base Year Value (2023)	USD 39,097.7 million
Final Value (2024)	USD 40,845.2 million
Estimated Growth (2019 to 2023)	3.6% CAGR

• In healthcare organizations, using chemical agents and disinfectants for extended periods may result in inevitable problems. These are the things that, because of their poisonous nature, deteriorate when they come into direct contact with chemicals in excessive concentrations.
• Chronic exposure can occasionally result in long-term health problems and illnesses, including cancer, headaches, respiratory irritation, mutagenic alterations, and dyspnea. These constraints are anticipated to stymie the expansion of the infection control industry.
• Additional testing parameters have also been included to demonstrate the sterility of medical devices, disinfectants, and sterilizing equipment. Players in the infection prevention industry will also face challenges due to the health and environmental risks linked with these compounds.

Consumption Analysis of the Infection Prevention Market

• Increased public awareness creates profitable development prospects for the sector. The market for recyclable and ecologically friendly infection control products, including biodegradable gloves, environmentally friendly packaging, and eco-friendly production techniques, is growing. Manufacturers are attempting to lower their carbon footprints and waste production.
• Plant-based polymers developed from sustainable resources like cellulose, sugarcane, or cornstarch are increasingly popular in producing biodegradable infection control products. These polymers can make packaging materials, disposable gowns, gloves, and aprons. Infection control products that are both biodegradable and ecological have driven market growth.
• Globally, there is a growing need for strategies to mitigate the risk of transmission and address the underlying cause of illness, as seen by the rise in infection cases. Reimbursing revenues are anticipated due to the healthcare industry's growing demand for items such as consumables, disinfectors, and sterilizing equipment.
• Customers are anticipated to want infection-prevention items as they become more aware of their cleanliness and health. Growing sales potential is expected due to the aging population's increasing need for improved healthcare.
• Hospital infections are mainly provoked by infections such as MRSA, pneumonia, urinary tract infections, bloodstream infections, and surgical site infections. Catheter-associated bloodstream infections, ventilator-associated pneumonia, and urinary tract infections are some central hospital-acquired infections (HAIs). HAIs are a severe problem for the industry because they have an influence on patient recovery, which in turn has a significant impact on worldwide mortality rates.

Top Product Insights

Consumables Acquires Significant Market Share of Infection Prevention Systems

Top Product	Consumables
Market share	41.0%

• The consumables segment led the global infection prevention market, accounting for 41.0%. The consumables sector has a significant market share, given its constant usage and short life cycle.
• These are often employed in disinfection, sterilization, and various other control processes, and they are necessary for treatments. Protective apparel and textiles had a significant market share in consumables.
• High consumption in the healthcare sectors to sterilize lines, surfaces, equipment, and devices is a central contributing element.

Top End User Insights

Hospitals & Clinics Cures Healthcare-Associated Infections

Top End User	Hospitals & Clinics
Market share	45.4%

• The global infection prevention market was dominated by the hospitals & clinics sector, which had a 45.4% share.
• Since hospital-acquired illnesses represent one of the industry's significant obstacles, strict management is necessary. Hospitals and public health groups have been pushed to implement highly efficient control systems.
• Throughout the projection period, the segment is expected to grow gradually. The elements driving category growth are an aging population, a rise in hospitalization, and an increase in surgical operations worldwide.

Country-wise Insights

Sterilization Technologies Market Development Booms in the United States

Country	United States
CAGR (2024 to 2034)	1.4%

• The infection prevention market in the United States is expected to grow at an average of 1.4% over the next decade.
• Rising awareness among healthcare practitioners is likely to drive demand countrywide for industrial cleansers and disinfectants.
• The expansion of the infection prevention market is anticipated to be aided by higher United States expenditure on healthcare infrastructure.
• For instance, Advanced Sterilization Products debuted the STERRAD 100NX System with ALLClear in the United States in January 2017 and expects to extend its reach globally.

Remarkable Growth of Infection Prevention & Control Market in China

Country	China
CAGR (2024 to 2034)	4.0%

• The infection prevention market in China is expected to expand rapidly. With a CAGR of 4.0%, China is predicted to lead the way in the worldwide market by 2034.
• The need for infection prevention goods is anticipated to soar due to the government's ongoing monitoring of population growth and newly identified cases.
• Additionally, the market prospects will be enhanced by the growing use of these goods to fend against any prospective viral infection.
• Chinese market players prioritize new product releases and utilize inorganic growth techniques, such as collaborating with regional companies, to expand their services.

Indian Government Provides Fertile Ground to Antimicrobial Solutions

Country	India
CAGR (2024 to 2034)	4.6%

• The India infection prevention industry has been dominating the global market with a CAGR of 4.6%, indicating a bright future for the market in the coming decade.
• India is expected to significantly contribute to the South Asian infection control market due to rising healthcare spending and improved healthcare access.
• The Indian government's ‘Special Campaign 2.0,’ focusing on cleanliness and sound governance, is expected to boost market share in the projected timeframe.
• Moreover, improved medical care facilities and healthcare services are expected to bolster the infection prevention market.

Hospitals in the United Kingdom Cultivates Infection Control Market Growth

Country	United Kingdom
CAGR (2024 to 2034)	2.0%

• The market in the United Kingdom is expected to evolve at a CAGR of 2.0% between 2024 and 2034.
• The growing requirement to maintain and adhere to hygienic procedures privately and in healthcare institutions fuels growth.
• Implementing infection prevention and control programs at the national level is expected to increase market share, particularly in acute healthcare facilities.
• The majority of heart bypass procedures in Europe are performed in hospitals in the United Kingdom. As a result, it is a critical necessity for worldwide infection prevention.

German Healthcare Market Provides Lucrative Opportunities for Infection Prevention

Country	Germany
CAGR (2024 to 2034)	1.9%

• Germany is predicted to record an average 1.9% CAGR from 2024 to 2034, owing to increased outsourcing endeavors, healthcare expenditure, and remarkable advancements in healthcare standards and infrastructure across the country.
• As one of the crucial aspects contributing to the country's development, the government and healthcare institutions are concentrating more on increasing infection control standards.
• The expansion of medical device and pharmaceutical enterprises in the country is likely to create profitable potential for market players.

Competitive Landscape in the Infection Prevention Market

The global infection prevention industry is competitive since significant firms are critical to generating new market growth strategies. Leading corporations dominate the competition through collaborative methods such as mergers and acquisitions, innovative product creation, and geographical growth.

During the anticipated period, key players are likely to take the lead, participating in investments, product development, and exclusive marketing agreements to extend their market presence and substantially contribute to market growth.

Recent Developments in the Infection Prevention Market

• In November 2023, a research team at Washington State University created a revolutionary 3D-printed surgical device that, in laboratory tests, killed 87% of the germs that provoke staph infections.
• In October 2023, Protection Paints created Vira-Protect, a long-lasting, efficient paint to aid in infection control, the paint source of silver ions mixed with water-based paint-compatible polyurethane.
• In September 2023, Sodexo and Ecolab partnered to combat hospital-acquired infections (HAIs) using Ecolab's Bioquell hydrogen peroxide vapor technology, reducing disease risk in healthcare facilities.
• In August 2023, Fortive company Advanced Sterilization Products introduced the STERRAD VELOCITY, a biological indicator/process challenge device for rapid and reliable sterilization of medical devices in Asia.
• In June 2023, Nanosonics introduced Nanosonics AuditPro, a digital infection prevention tool designed to assist healthcare practitioners in measuring and managing their infection prevention operations.

Key Companies in the Infection Prevention Market

• STERIS PLC (Cantel Medical Corporation)
• Belimed AG
• Matachana Group
• Halyard Health Inc.
• Ecolab Inc.
• Miele Group. (Steelco)
• MMM Group
• Pal Internation
• Metrex Research
• Sotera Health Inc.
• 3M Company
• Matachana Group
• Steris Corporation
• Reckitt Benckiser
• Getinge Group
• Sterigenics International Inc.
• Fortive Corporation (Advanced Sterilization Products)

Market Segmentation

By Product:

• Sterilization Equipment
  • Low-Temperature Equipment
  • Heat Sterilization Equipment
  • Radiation Sterilization Equipment
  • Liquid Sterilization Equipment
• Disinfectors
  • Washer Disinfectors
  • Endoscope Repressors
  • Flusher Disinfectors
  • Surface Disinfectants
  • Hand Sanitizers
• Consumables
  • Sterilization Supplies
  • Protective Apparel & Textiles
  • Infectious Waste Disposal

By End User:

• Hospitals & Clinics
• Pharmaceutical Companies
• Clinical Laboratories
• Medical Device Companies
• Life Science Industry
• Academic and Research Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East & Africa

Frequently Asked Questions

What is the Future of the Infection Prevention Industry?

The infection prevention market is estimated to increase at a 3.10% CAGR between 2024 and 2034, reaching USD 55,379.1 million.

What is the Size of the Infection Prevention Market in India?

The Indian infection prevention sector captures the global market with a CAGR of 4.6%.

Which are the Top Five Countries Driving Demand for Infection Prevention?

The United States, the United Kingdom, China, India, and Germany are the top five countries driving the demand for infection prevention.

How Much is the Global Infection Prevention Market Worth in 2023?

The global infection prevention market is worth USD 40,845.2 million in 2023.

Which Products Have Been Dominating the Global Infection Prevention Market?

Consumables are anticipated to dominate the global market with a 41.0% market share.